FreeIn the Archives Rutgers archives: Joseph R. Bertino on genomics and cancer risk December 09, 2022Vol.48 No.44
FDA, NCI align to simplify clinical research, producing a model “pragmatic” registration trial in NSCLC December 02, 2022Vol.48 No.43By Jacquelyn Cobb, Matthew Bin Han Ong and Paul Goldberg
Conversation with The Cancer Letter Roy Herbst: I hope Pragmatica-Lung will become the norm December 02, 2022Vol.48 No.43By Jacquelyn Cobb and Paul Goldberg
Conversation with The Cancer Letter Ellen Sigal: Pragmatica-Lung may be a model for other trials that are unnecessarily complex December 02, 2022Vol.48 No.43By Matthew Bin Han Ong
FreeObituary UNC’s Jo Anne Earp, behavioral scientist and civil rights activist, dies at 79 December 02, 2022Vol.48 No.43By Elizabeth French
FreeIn the Archives Podcasts, panels, and archives of the first NCI-designated cancer centers December 02, 2022Vol.48 No.43
Conversation with The Cancer Letter Joseph Califano named director of UCSD Moores Cancer Center November 18, 2022Vol.48 No.42By Paul Goldberg
Conversation with The Cancer Letter Nature Medicine paper confirms clinical utility of liquid biopsies in routine care for lung cancerCohort study finds significant OS benefit in NSCLC with targetable ctDNA alterations November 18, 2022Vol.48 No.42By Matthew Bin Han Ong
Guest Editorial A “new normal” for NCI-sponsored clinical trials is long overdue November 18, 2022Vol.48 No.42By Richard L. Schilsky
Guest Editorial Lung cancer screening: New guidelines, new challenges November 18, 2022Vol.48 No.42By David Balis
